COPD treatment: Real life and experimental effects on peripheral NK cells, their receptors expression and their IFN-γ secretion

Pulmonary Pharmacology and Therapeutics

Volumn 25, Issue 5, 2012, Pages 371-376

  Folli, C ^a   Chiappori, A ^a   Pellegrini, M ^b   Garelli, V ^a   Riccio, A M ^a   De Ferrari, L ^a   Braido, F ^a   Canonica, G W ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b ASTRAZENECA   (United Kingdom)

Author keywords

Budesonide; COPD; Formoterol; IFN ; Natural Killer cell receptors; Natural Killer cells

Indexed keywords

BUDESONIDE; FLUTICASONE; FORMOTEROL; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2D; SALBUTAMOL; SALMETEROL; TIOTROPIUM BROMIDE;

AGED; ARTICLE; CELL ISOLATION; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE COUNT; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPERNATANT;

AGED; BUDESONIDE; ETHANOLAMINES; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-2; KILLER CELLS, NATURAL; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84865976309     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2012.06.009     Document Type: Article

References (26)

1. Hogg J.C., Chu F., Utokaparch S., Woods R., Elliott W.M., Buzatu L., et al. The nature of small airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004, 350(26):2645-2653.
2. Huertas A., Palange P. COPD: a multifactorial systemic disease. Ther Adv Respir Dis 2011, 5(3):217-224.
3. Pinto-Plata V., Toso J., Lee K., Park D., Bilello J., Mullerova H., et al. Profiling serum biomarkers in patients with COPD: associations with clinical parameters. Thorax 2007, 62:595-601.
4. Dickens J.A., Miller B.E., Edwards L.D., Silverman K.E. Lomas DA and Tal-Singer R. COPD association and repeatability of blood biomarkers in the ECLIPSE cohort. Respir Res 2011, 4(12):146-156.
5. Braido F., Riccio A.M., Guerra L., Gamalero C., Zolezzi A., Tarantini F., et al. Clara cell 16 protein in COPD sputum: a marker of small airways damage?. Respir Med 2007, 101(10):2119-2124.
6. Cosio M.G., Saetta M., Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009, 360(23):2445-2454.
7. Culley F.J. Natural killer cells in infection and inflammation of the lung. Immunology 2009, 128(2):151-163.
8. Cooper M.A., Fehniger T.A., Caligiuri M.A. The biology of human natural killer-cell subsects. TRENDS in Immunol 2001, 22(11):633-640.
9. Vivier E., Tomasello E., Baratin M., Walzer T., Ugolini S. Functions of natural killer cells. Nat Immunology 2008, 9(5):503-510.
10. Moretta A., Marcenaro E., Parolini S., Ferlazzo G., Moretta L. NK cells at the interface between innate and adaptive immunity. Cell Death and Differentiation 2008, 15:226-233.
11. Crim C., Calverley P.M., Anderson J.A., Celli B., Ferguson G.T., Jenkins C., et al. Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur Respir J 2009, 34(3):641-647.
12. Hankinson J.L., Odencratz J.R., Fedan K.B. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999, 159(1):179-187.
13. Pellegrino R., Viegi G., Brusasco V., Crapo R.O., Burgos F., Casaburi R., et al. Interpretative strategies for lung function tests. Eur Respir J 2005, 26(5):948-968.
14. Urbanowicz R.A., Lamb J.R., Todd I., Corne J.M., Fairclough L.C. Altered effector function of peripheral cytotoxic cells in COPD. Respiratory Research 2009, 10:53-65.
15. Zhou J., Olsen S., Moldovan J., Fu X., Sarkar F.H., Moudgil V.K., et al. Glucocorticoid regulation of natural cytotoxicity: effects of cortisol on the phenotype and function of a cloned human natural killer cell line. Cell Immunol 1997, 178:108-116.
16. Oshimi K., Gonda N., Sumiya M., Kano S. Effects of corticosteroids on natural killer cellactivity in systemic lupus erythematosus. Clin Exp Immunol 1980, 40:83-88.
17. Vitale C., Chiossone L., Cantoni C., Morreale G., Cottalasso F., Moretti S., et al. The corticosteroid-induced inhibitory effect on NK cell function reflects down-regulation and/or dysfunction of triggering receptors involved in natural cytotoxicity. Eur J Immunol 2004, 34:3028-3038.
18. Smyth M.J., Swann J., Kelly J.M., Cretney E., Yokoyama W.M., Diefenbach A., et al. NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer. J Exp Med 2004, 10:1325-1335.
19. Lu C.C., Chen J.K. Resveratrol enhances perforin expression and NK cell cytotoxicity through NKG2D-dependent pathways. J Cell Physiol 2010, 223:343-345.
20. Konjević G., Mirjačić Martinović K., Vuletić A., Radenković S. Novel aspects of in vitro IL-2 or IFN-α enhanced NK cytotoxicity of healthy individuals based on NKG2D and CD161 NK cell receptor induction. Biomed Pharmacother 2010, 64(10):663-671.
21. Raulet D.H. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 2003, 3:781-790.
22. Diefenbach A., Hsia J.K., Hsiung M.Y., Raulet D.H. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity. Eur J Immunol 2003, 33:381-391.
23. Casado J.G., Pawelec G., Morgado S., Sanchez-Correa B., Delgado E., Gayoso I., et al. Expression of adhesion molecules and ligands for activating and costimulatory receptors involved in cell mediated cytotoxicity in a large panel of human melanoma cell lines. Cancer Immunol Immunother 2009, 58:1517-1526.
24. Motz G.T., Eppert B.L., Wortham B.W., Amos-Kroohs R.M., Flury J.L., Wesselkamper S.C., et al. Chronic cigarette smoke exposure primes NK cell activation in a mouse model of chronic obstructive pulmonary disease. J Immunol 2010, 184(8):4460-4469.
25. Mian M.F., Lauzon N.M., Stämpfli M.R., Mossman K.L., Ashkar A.A. Impairment of human NK cell cytotoxic activity and cytokine release by cigarette smoke. J Leukoc Biol 2008, 83(3):774-784.
26. Wang Z., Zheng T., Zhu Z., Homer R.J., Riese R.J., Chapman H.A., et al. Interferon gamma induction of pulmonary emphysema in the adult murine lung. J Exp Med 2000, 192(11):1587-1600.